Investing.com - Biomerica (NASDAQ:BMRA) reported on Tuesday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Biomerica announced earnings per share of $-0.160 on revenue of $1.640. Analysts polled by Investing.com anticipated EPS of $-0.020 on revenue of $2.7M.
Biomerica shares are down 4.88% from the beginning of the year, still down 39.34% from its 52 week high of $6.10 set on October 19, 2021.
Biomerica follows other major Healthcare sector earnings this month
Biomerica's report follows an earnings beat by UnitedHealth on Friday, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
Exelixis had beat expectations on August 9 with second quarter EPS of $0.22 on revenue of $419.43M, compared to forecast for EPS of $0.203 on revenue of $391.03M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar